Akihl Suresh

Dr. Akihl Suresh

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RNReema Narayan
Reema Narayan
SGShivaprasad Gadag
Shivaprasad Gadag
SCSri Pragnya Cheruku
Sri Pragnya Cheruku
ARAshok M. Raichur
Ashok M. Raichur
Candace Minhthu DayCandace Minhthu Day
Candace Minhthu Day
UNUsha Yogendra Nayak
Usha Yogendra Nayak

1 March 2022 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
SMSwapnil Mehta
Swapnil Mehta
ASAkihl Suresh
Akihl Suresh
UNUsha Y Nayak
Usha Y Nayak
RNReema Narayan
Reema Narayan
UNUsha Y Nayak
Usha Y Nayak

1 April 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
KBKrishnaprasad Baby
Krishnaprasad Baby
SMSwastika Maity
Swastika Maity
Chetan MehtaChetan Mehta
Chetan Mehta
ASAkihl Suresh
Akihl Suresh
UNUsha Y Nayak
Usha Y Nayak
UNUsha Y Nayak
Usha Y Nayak

22 November 2021 in 3 Biotech
Verified
Journal Article
Open access
PDF file
FRFiona C. Rodrigues
Fiona C. Rodrigues
GHGangadhar Hari
Gangadhar Hari
KPK. Sreedhara Ranganath Pai
K. Sreedhara Ranganath Pai
ASAkihl Suresh
Akihl Suresh
UNUsha Y Nayak
Usha Y Nayak
GTGoutam Thakur
Goutam Thakur
The human Abl kinases comprise a family of proteins that are known to be key stimulus drivers in the signaling pathways modulating cell growth, cell survival, cell adhesion, and apoptosis. Recent collative studies have indicated the role of activation of Abl and Abl-related genes in solid tumors; further terming the Abl kinases as molecular switches which promote proliferation, tumorigenesis, and metastasis. The up-regulated Abl-kinase expression in colorectal cancer (CRC) and the role of Abl tyrosine kinase activity in the Matrigel invasion of CRC cells have cemented its significance in CRC advancement. Therefore, the requisite of identifying small molecules which serve as Abl selective inhibitors and designing anti-Abl therapies, particularly for CRC tumors, has driven this study. Curcumin has been touted as an effective inhibitor of cancer cells; however, it is limited by its physicochemical inadequacies. Hence, we have studied the behavior of heterocyclic derivatives of curcumin via computational tools such as pharmacophore-based virtual screening, molecular docking, free-energy binding, and ADME profiling. The most actively docked molecule, 3,5-bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-carboxamide, was comparatively evaluated against Curcumin via molecular dynamics simulation using Desmond, Schrödinger. The study exhibited the improved stability of the derivative as compared to Curcumin in the tested protein pocket and displayed the interaction bonds with the contacted key amino acids. To further establish the claim, the derivatives were synthesized via the mechanism of cyclization of Curcumin and screened in vitro using SRB assay against human CRC cell line, HCT 116. The active derivative indicated an IC50 value of 5.85 µM, which was sevenfold lower as compared to Curcumin’s IC50 of 35.40 µM. Hence, the results base the potential role of the curcumin derivative in modulating Abl-kinase activity and in turn may have potential therapeutic value as a lead for CRC therapy.

12 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
VVVaralakshmi Velagacherla
Varalakshmi Velagacherla
ASAkihl Suresh
Akihl Suresh
Chetan MehtaChetan Mehta
Chetan Mehta
UNUsha Y Nayak
Usha Y Nayak
UNUsha Y Nayak
Usha Y Nayak
The coronavirus disease (COVID-19) is a pandemic that started in the City of Wuhan, Hubei Province, China, caused by the spread of coronavirus (SARS-CoV-2). Drug discovery teams around the globe are in a race to develop a medicine for its management. It takes time for a novel molecule to enter the market, and the ideal way is to exploit the already approved drugs and repurpose them therapeutically. We have attempted to screen selected molecules with an affinity towards multiple protein targets in COVID-19 using the Schrödinger suit for in silico predictions. The proteins selected were angiotensin-converting enzyme-2 (ACE2), main protease (MPro), and spike protein. The molecular docking, prime MM-GBSA, induced-fit docking (IFD), and molecular dynamics (MD) simulations were used to identify the most suitable molecule that forms a stable interaction with the selected viral proteins. The ligand-binding stability for the proteins PDB-IDs 1ZV8 (spike protein), 5R82 (Mpro), and 6M1D (ACE2), was in the order of nintedanib > quercetin, nintedanib > darunavir, nintedanib > baricitinib, respectively. The MM-GBSA, IFD, and MD simulation studies imply that the drug nintedanib has the highest binding stability among the shortlisted. Nintedanib, primarily used for idiopathic pulmonary fibrosis, can be considered for repurposing for us against COVID-19.

30 November 2020 in Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
BKBaby Krishnaprasad
Baby Krishnaprasad
SMSwastika Maity
Swastika Maity
Chetan MehtaChetan Mehta
Chetan Mehta
ASAkihl Suresh
Akihl Suresh
UNUsha Y Nayak
Usha Y Nayak
UNUsha Y Nayak
Usha Y Nayak
Background: SARS coronavirus-2 (SARS-CoV-2) infection causes Novel Coronavirus Disease (COVID-19). It is a respiratory tract infection and currently becoming pandemic worldwideaffecting more than 50 lakh people. As of now, there is no treatment or vaccine developed for disease management. The main protease, Mpro in SARS-CoV-2 is a druggable target explored by many scientists. We targeted this with the well-known approach of drug repurposing by using computational tools. Methods: Schrödinger software was used for the study. Ligands were prepared from US-FDA drug-bank by importing it to Maestro graphical user interphase, optimised using LigPrep, and molecular geometry minimized using OPLS3e force-field. Mpro crystal structure 6LU7 was downloaded from PDB and optimised. Molecules were docked using CovDock module in Glide docking. Further, molecular dynamics simulations were carried out for 100 ns using Desmond module. Results: In docking and molecular interactions studies, penicillins emerged as hits with consistent binding pattern by forming hydrophilic, hydrophobic, electrostatic interactions. The molecular dynamics simulations confirmed the interactions. Phenoxymethylpenicillin and Carbenicillin were found to interact consistently and appeared to be the most promising. Conclusion: Usually, antibiotics are discouraged from using in the viral pandemic because of the development of resistance. Azithromycin was combined with hydroxychloroquine to treat COVID-19. Penicillins are less potent and first-line antibiotics for most of the bacterial infections. This study suggests Phenoxymethylpenicillin and Carbenicillin can be tried along with hydroxychloroquine. Further, this study shows the possible exploration by drug repurposing using computer-aided docking tools and the potential roles of beta-lactams in COVID-19.